ArticleInternational journal of molecular sciences2025
Dual Therapeutic Impact of AXL Inhibitor AB-329: Chemotherapy Sensitization and Immune Microenvironment Reprogramming in TNBC.
Dileep Reddy Rampa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.